Navigation Links
EPA Approves XDS-CALUX(R) as Alternate Dioxin Test Method 4435
Date:5/30/2008

DURHAM, N.C., May 30 /PRNewswire/ -- Dr. George C. Clark of Xenobiotic Detection Systems (XDS) and Dr. Michael Denison at the University of California Davis, with support from the Superfund Basic Research Program, have developed a rapid and inexpensive recombinant cell bioassay system for the detection and relative quantification of dioxin-like chemicals. Dioxin-like chemicals are some of the most toxic chemicals known.

The CALUX(R) by XDS (Chemical Activated LUciferase Gene Expression) system has recently been published and is posted under "New Methods" on the SW-846 website. In March 2008, the EPA's Office of Solid Waste (OSW) Organic Methods Workgroup formally reviewed and approved Method 4435 for inclusion into Test Methods for Evaluating Solid Waste, Physical/Chemical Methods, also known as SW-846. The XDS-CALUX system consists of a unique sample processing method linked with a sensitive gene expression cell bioassay detection system providing unique sensitivity and selectivity for quantifying dioxin-like chemicals.

The XDS-CALUX(R) bioassay costs are 40%-70% lower than the traditional High Resolution Gas Chromatography/Mass Spectrometry (HR GC/MS) that was the old singular analysis standard. Xenobiotic Detection Systems Method 4435 provides an excellent screening tool to rapidly detect and quantify these ubiquitous and toxic environmental contaminants.

"This approval exemplifies the assay's versatility and is another major step for XDS," says President of XDS, Dr. George Clark. "Having been certified in the European Union since 2002 to primarily monitor feed and food it is wonderful to receive accreditation here in the U.S. Our screening analysis method is faster, far more affordable, and in many cases even more sensitive than the traditional HR GC/MS. The EPA's approval will allow us to better serve our clients and safeguard the environment from these toxic contaminants."

Research Institutes Worldwide using XDS-CALUX(R) Tech
'/>"/>

SOURCE Xenobiotic Detection Systems
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
3. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
4. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
5. FDA Approves MiddleBrooks Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
6. FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
7. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
8. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
9. U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
10. FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer
11. Endoscopy Identified as Safe and Effective Method in Treating Common Complication of Gastric Bypass Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... 26, 2015 Cardiologists at Beaumont Hospital, ... first commercial implant of a device recently approved by ... atrial fibrillation. The Watchman Left Atrial Appendage Closure implant ... medication to reduce the risk of stroke. ... affecting more than 5 million Americans. Twenty percent of ...
(Date:3/26/2015)... Over-the-counter healthcare costs can be a ... new survey of store brand over-the-counter products aimed ... to diabetes, can offer significant savings for those ... Private Label Manufacturers Association, assembled a market basket ... essential for treatment of pre-diabetes and diabetes. These ...
(Date:3/26/2015)... LAS VEGAS , March 26, 2015 ... its Vivacit-E ® Advanced Bearing Technology ... A paper published earlier this month reported ... testing, Vivacit-E Advanced Bearing Technology featuring Vitamin ... Zimmer maintained a significant wear rate reduction of 95 ...
Breaking Medicine Technology:Beaumont Hospital, Royal Oak among first to offer alternative to blood-thinning medications for atrial fibrillation 2Beaumont Hospital, Royal Oak among first to offer alternative to blood-thinning medications for atrial fibrillation 3Consumers can keep over-the-counter medicine affordable by using store brands 2Zimmer Announces New Testing Milestone For Vitamin E Advanced Bearing Technology 2Zimmer Announces New Testing Milestone For Vitamin E Advanced Bearing Technology 3
(Date:3/26/2015)... Tarrytown, NY (PRWEB) March 26, 2015 ... conducted its 30th “Introduction to Hyperbaric Medicine” course, ... Hyperbaric Medical Society (UHMS) and the National Board ... LST provides the 40-hour course 4 times a ... facilities around the NY tri-state region; registration is ...
(Date:3/26/2015)... Innovative research and additional funding ... often fatal ruptures, says The Bee Foundation, a ... of brain aneurysms and funding innovative research that ... attention with the death of longtime WABC-TV ... Friday after suffering a ruptured brain aneurysm. (Source: ...
(Date:3/26/2015)... (PRWEB) March 26, 2015 On March ... Wesley Matthews is out for the season with a ... occurred while the Trail Blazers were competing against Dallas, ... medicine specialist, Izzy Silva, M.D., who has treated ... injury and whether it could be prevented. , ...
(Date:3/26/2015)... Md. (PRWEB) March 26, 2015 ... supports the Patients’ Access to Treatments Act (PATA) ... this week by Reps. David B. McKinley (R-WV) ... will limit cost-sharing requirements for medications placed in ... accessible by reducing patients’ out-of-pocket expenses. , This ...
(Date:3/26/2015)... (PRWEB) March 26, 2015 Volunteers will ... awareness of Parkinson’s disease and funds to support the ... Ease the Burden – Find the Cure. ... will take place in more than 20 locations including, ... New Jersey, San Antonio, Minnesota, Seattle, St. Louis, New ...
Breaking Medicine News(10 mins):Health News:The Life Support Technologies Group (LST) Conducted its 30th Accredited “Introduction to Hyperbaric Medicine” Course for Health Care Professionals 2Health News:The Life Support Technologies Group (LST) Conducted its 30th Accredited “Introduction to Hyperbaric Medicine” Course for Health Care Professionals 3Health News:The Life Support Technologies Group (LST) Conducted its 30th Accredited “Introduction to Hyperbaric Medicine” Course for Health Care Professionals 4Health News:Research and Funding Are Keys to Raising Awareness and Ultimately Preventing Fatal Brain Aneurysm Ruptures 2Health News:Research and Funding Are Keys to Raising Awareness and Ultimately Preventing Fatal Brain Aneurysm Ruptures 3Health News:Sports Medicine Specialist Weighs In on Wesley Matthew’s Significant Tendon Injury; Can it be Prevented? 2Health News:Sports Medicine Specialist Weighs In on Wesley Matthew’s Significant Tendon Injury; Can it be Prevented? 3Health News:Sports Medicine Specialist Weighs In on Wesley Matthew’s Significant Tendon Injury; Can it be Prevented? 4Health News:Pulmonary Hypertension Association Part of Coalition Supporting the Patients’ Access to Treatments Act 2Health News:American Parkinson Disease Association 2015 Optimism Walk Season Launches Nationwide 2
... , EXTON, Pa., Oct. 15 ViroPharma Incorporated,s (Nasdaq: ... to be released on Wednesday, October 28, 2009 before the ... host a conference call and live audio webcast at 9:00 ... conference call, ViroPharma management will discuss the 2009 third quarter ...
... researchers say , THURSDAY, Oct. 15 (HealthDay News) -- ... of people, potentially paving the way toward better treatments ... a crucial step forward towards developing therapies that can ... the only treatment for most advanced liver disease," the ...
... 15 Bausch & Lomb today announced the launch of ... Patient Insights at www.CenterForPatientInsights.com . The Center, ... to eye care professionals to help them better understand and ... information and serve as an easy-to-use point of entry for ...
... COAST, Fla., Oct. 15 Technology companies have been ... Incubator space has recently gathered some thoughtful discussion in ... the expansion of medical care into secondary markets. One ... , believes there,s application in off-campus medical office buildings ...
... vaccine might promote promiscuity, a national survey of girls ... did not believe the HPV vaccine protected them against ... University of Illinois at Chicago and University of Chicago ... the Journal of Adolescent Health . The ...
... technique described as a Band-Aid for damaged muscle , THURSDAY, ... toward the goal of literally rebuilding a broken heart -- ... by using a newly identified human cardiac master stem cell. ... therapy," said Dr. Kenneth Chien, director of the Massachusetts General ...
Cached Medicine News:Health News:ViroPharma to Release 2009 Third Quarter Financial Results on October 28, 2009 2Health News:Liver Cells Made to Order 2Health News:Center for Patient Insights Web Site Goes Live 2Health News:Oaks Development Group Launches Physician Incubator Space in Palm Coast Medical Office Building 2Health News:UIC study finds girls aware of HPV vaccine's benefits 2Health News:Stem Cells Grow Heart Tissue in Lab 2Health News:Stem Cells Grow Heart Tissue in Lab 3
This compact photomicrographic system assures simple operation to achieve the exposure accuracy required for sophisticated photomicrography in most research and clinical environments....
... Hema-G Stains for Geometric Data ... performance. Stains are quality control ... to ensure proper staining and ... most applications for a minimum ...
... suspension in methanol for faster, more ... histology smears. Our special manufacturing process ... cellular elements producing unequaled definition of ... unexcelled brilliance in the resulting smear. ...
... For fast, single-solution staining, Hema-Quik ... Dip slides into stain solution ... transfer to deionized water for ... a second time by dipping ...
Medicine Products: